Amyloid A in systemic amyloidosis associated with cancer.
Amyloid fibrils from two cases of cancer-associated, systemic amyloidosis with renal cell carcinoma and mesothelioma as the respective underlying disorders were studied. The immunochemical studies suggested strongly that amyloid A comprised a principal fibril component in both cases of cancer-associated amyloidosis. This was definitively proven by amino acid sequence analyses, which revealed structural homology between a purified subcomponent of the amyloid fibrils from both of the two cases of cancer-associated amyloidosis and previously sequenced amyloid A proteins. The chemical composition of the amyloid fibrils from systemic amyloidosis associated with cancer thus corresponded to that seen in amyloidosis reactive to inflammatory diseases and Hodgkin's disease. Amyloid proteins of immunoglobulin light chain type, which are found associated with myelomatosis, macroglobulinemia, and idiopathic (primary) amyloidosis, were not found in the two amyloid preparations. Renal cell carcinoma appears to be an effective stimulator of amyloid formation, while only one case of amyloidosis associated with mesothelioma has been reported previously.
D000293:Adolescent; D000595:Amino Acid Sequence; D000682:Amyloid / Q000032:analysis*; D000686:Amyloidosis / Q000378:metabolism*; D002850:Chromatography, Gel; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism; D008297:Male; D008654:Mesothelioma / Q000378:metabolism; D008875:Middle Aged; D009369:Neoplasms / Q000378:metabolism*; D012186:Retroperitoneal Neoplasms / Q000378:metabolism; D000685:Serum Amyloid A Protein / Q000032:analysis* / Q000276:immunology / Q000378:metabolism
D000682:Amyloid; D000685:Serum Amyloid A Protein